Inhibiting cardiomyocytes glycolysis or promoting oxidative phosphorylation can effectively alleviate pathological cardiac hypertrophy.[5] Our study is the first to report that cardiomyocyte Lgr6 inhibits PO‐induced glycolysis and promotes oxidative phosphorylation. Here, LGR6 is linked to cardiac hypertrophy.